The discussion highlights the strong correlation between public opinion on vaccine confidence and actual vaccination rates in the U.S. Daniel emphasizes the importance of procedural integrity in the FDA's approval process, illustrating how perceived irregularities can lead to rational hesitancy among informed purchasers. The conversation also touches on the need for continuous study of drugs post-approval to ensure long-term safety and efficacy.
